logo

For the Inventor, By the Inventor

The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Patent No.:

US 10745382 B1

PDFFull Text
Date of Patent:
Aug. 18, 2020

Filed:

Oct. 11, 2016

Compounds useful as immunomodulators

Applicant:

Bristol-myers Squibb Company, Princeton, NJ (US);

Inventors:

Kap-Sun Yeung, Madison, CT (US);

Timothy P. Connolly, Kenosha, WI (US);

David B. Frennesson, Naugatuck, CT (US);

Katharine A. Grant-Young, Madison, CT (US);

Piyasena Hewawasam, Middletown, CT (US);

David R. Langley, Meriden, CT (US);

Zhaoxing Meng, Middletown, CT (US);

Eric Mull, Guilford, CT (US);

Kyle E. Parcella, Wallingford, CT (US);

Mark George Saulnier, Higganum, CT (US);

Li-Qiang Sun, Glastonbury, CT (US);

Alan Xiangdong Wang, Wallingford, CT (US);

Ningning Xu, Wallingford, CT (US);

Juliang Zhu, North Haven, CT (US);

Paul Michael Scola, Glastonbury, CT (US);

Assignee:

bristol-myers squibb company, princeton, NJ (US);

Attorney:

Sterne, Kessler, Goldstein & Fox P.L.L.C.

Primary Examiner:

Brian J Davis

Int. Cl.
CPC ...
C07D 401/14 (2006.01); C07D 213/71 (2006.01); C07D 455/02 (2006.01); A61K 31/135 (2006.01); A61K 31/138 (2006.01); A61K 31/166 (2006.01); A61K 31/397 (2006.01); A61K 31/40 (2006.01); A61K 31/4025 (2006.01); A61K 31/44 (2006.01); A61K 31/4427 (2006.01); A61K 31/4439 (2006.01); A61K 31/4453 (2006.01); A61K 31/454 (2006.01); A61K 31/4545 (2006.01); A61K 31/496 (2006.01); A61K 31/5375 (2006.01); A61K 31/5377 (2006.01); A61K 31/541 (2006.01); A61K 45/06 (2006.01); C07C 215/20 (2006.01); C07C 235/46 (2006.01); C07D 205/04 (2006.01); C07D 207/12 (2006.01); C07D 207/14 (2006.01); C07D 207/16 (2006.01); C07D 211/22 (2006.01); C07D 213/80 (2006.01); C07D 213/82 (2006.01); C07D 213/85 (2006.01); C07D 265/30 (2006.01); C07D 401/12 (2006.01); C07D 403/12 (2006.01); C07D 405/12 (2006.01); C07D 405/14 (2006.01); C07D 413/14 (2006.01); C07D 417/12 (2006.01); C07D 417/14 (2006.01); C07D 471/04 (2006.01); C07D 471/08 (2006.01); C07D 491/08 (2006.01);
U.S. Cl.
CPC ...
C07D 401/14 (2013.01); A61K 31/135 (2013.01); A61K 31/138 (2013.01); A61K 31/166 (2013.01); A61K 31/397 (2013.01); A61K 31/40 (2013.01); A61K 31/4025 (2013.01); A61K 31/44 (2013.01); A61K 31/4427 (2013.01); A61K 31/4439 (2013.01); A61K 31/4453 (2013.01); A61K 31/454 (2013.01); A61K 31/4545 (2013.01); A61K 31/496 (2013.01); A61K 31/5375 (2013.01); A61K 31/5377 (2013.01); A61K 31/541 (2013.01); A61K 45/06 (2013.01); C07C 215/20 (2013.01); C07C 235/46 (2013.01); C07D 205/04 (2013.01); C07D 207/12 (2013.01); C07D 207/14 (2013.01); C07D 207/16 (2013.01); C07D 211/22 (2013.01); C07D 213/71 (2013.01); C07D 213/80 (2013.01); C07D 213/82 (2013.01); C07D 213/85 (2013.01); C07D 265/30 (2013.01); C07D 401/12 (2013.01); C07D 403/12 (2013.01); C07D 405/12 (2013.01); C07D 405/14 (2013.01); C07D 413/14 (2013.01); C07D 417/12 (2013.01); C07D 417/14 (2013.01); C07D 455/02 (2013.01); C07D 471/04 (2013.01); C07D 471/08 (2013.01); C07D 491/08 (2013.01); Y02A 50/463 (2018.01);
Abstract

The present disclosure generally relates to compounds useful as immunomodulators. Provided herein are compounds, compositions comprising such compounds, and methods of their use. The disclosure further pertains to pharmaceutical compositions comprising at least one compound according to the disclosure that are useful for the treatment of various diseases, including cancer and infectious diseases.

Find Patent Forward Citations

Loading…